Specialty Pharmacy Tech — Investigational Drug Services

MD Anderson Center; Houston (TX); On-site; USD 42,000 - 54,000; Full time

Benefits offered by this job

Medical benefits

Dental and Vision

Paid Time Off

Tuition Assistance

Retirement plans

Employer-paid life insurance

Employee wellness programs

Job summary

MD Anderson Cancer Center's Investigational Drug Services (IDS) Department seeks a detail-oriented Pharmacy Technician registered with the Texas State Board of Pharmacy. The role requires at least one year of pharmacy tech experience, with PTCB preferred, and a commitment to accuracy in a hospital infusion setting.

Ideal candidates excel in fast-paced environments, support patient treatment journeys, and uphold regulatory compliance while managing investigational drug accountability and

Qualifications

• Active Texas State Board of Pharmacy registration required.
• Minimum of one year of pharmacy technician experience in hospital, infusion center, retail, or specialty pharmacy.
• PTCB certification preferred.
• Strong accuracy, attention to detail, and patient-focused service.

Responsibilities

• Maintain investigational drug accountability with daily audits and inventory management.
• Support drug returns, replacements, and quarantine of expired inventory per guidelines.
• Maintain regulatory documentation such as Shipment Receipt Documentation and iDATA transactions.
• Perform other duties as assigned.

Skills

Attention to detail

Patient-focused

Organizational skills

Communication skills

Education

High School Diploma or equivalent

Some college coursework

Job description

MD Anderson Cancer Center's Investigational Drug Services (IDS) Department seeks a detail-oriented Pharmacy Technician registered with the Texas State Board of Pharmacy. The role requires at least one year of pharmacy tech experience, with PTCB preferred, and a commitment to accuracy in a hospital infusion setting.

Ideal candidates excel in fast-paced environments, support patient treatment journeys, and uphold regulatory compliance while managing investigational drug accountability and